Fourier Rehab and Kurage Announce Strategic Partnership to Advance Functional Rehabilitation Through Integrated NeuroSkin Technology
May 16, 2025
Chicago, United States, 16 May 2025 – Fourier Rehab, a global leader in robotic rehabilitation technology, captivated audiences at RehabWeek 2025. Held in Chicago from the 12th to 16th of May 2025, the company demonstrated its latest advancements in intelligent rehabilitation and human-centered robotics. The international event brought together clinicians, engineers, and researchers focused on advancing neurorehabilitation. Fourier Rehab stood out for its hands-on technology demonstrations, innovative engineering, and embodied artificial intelligence (AI) integration into clinical practice.
At RehabWeek 2025, Fourier Rehab showcased three of its flagship technologies:
Picture 1: Delegates experiencing the ArmMotus™ EMU during a live demonstration at RehabWeek 2025. Attendees explored the device’s immersive gamified therapy modes and experienced its advanced 3D cable-driven technology firsthand.
The IERA Award-winning ArmMotus™ EMU, featuring immersive gamified therapy, is designed for upper limb rehabilitation and offers treatment for various medical conditions. As the industry’s first 3D cable-driven upper limb end-effector with a de-weighting mechanism, it represents a significant breakthrough in rehabilitation robotics. Clinicians praised its versatility in effectively addressing multiple impairments affecting the upper extremities.
Picture 2: Delegates trying out the ExoMotus™ M4 during RehabWeek 2025. Visitors could experience the device’s innovative gait training capabilities and learn how it supports mobility recovery in a clinical setting.
ExoMotus™ M4 is also the first in the industry with an ergonomic body frame. It focuses on gait training to help individuals regain their mobility and confidence after injuries like stroke, traumatic brain injuries, post-brain surgery, spinal cord injury, and more. With patient safety as a top priority, it is designed to reduce the risk of falls during therapy, giving patients the confidence to move freely without fear, minimizing stress, and improving overall outcomes.
Picture 3: Attendees interacting with the GR-1 Humanoid Robot at RehabWeek 2025.
The GR-1 Humanoid Robot made its electrifying RehabWeek debut, showcasing Fourier Rehab’s most ambitious application of embodied AI to date. Clinicians were allowed to interact with the GR-1, which demonstrated functional human-like movement, paving the way for future applications in a clinical context.
Fourier Rehab announced the Embodied AI for Rehabilitation Technology Development Initiative in April 2025 at the GReAT 2025 summit. This initiative unites an international panel of experts in rehabilitation medicine, robotics, and AI to accelerate the creation of next-generation embodied AI rehabilitation solutions. At RehabWeek 2025, Fourier Rehab illustrated the early outcomes of this initiative through the GR-1.
Picture 4: Owen Teoh, Managing Director of Fourier Rehab International Division, with a delegate at the booth.
“While the Embodied AI Initiative was formally launched at GReAT 2025, RehabWeek allowed us to demonstrate a glimpse of its real-world potential. The GR-1 is not just a robot; it’s a glance into the future of rehabilitation, where intelligent machines act as partners in care. While our embodied AI program is still developing, the overwhelming response to GR-1 highlights a global readiness for solutions beyond automation—tools that learn, adapt, and partner with clinicians to transform care delivery at scale. We’re not just building robots; we’re shaping the next era of human-centered rehabilitation,” said Owen Teoh, Managing Director of Fourier Rehab International Division.
Picture 5: Fourier Rehab, a proud IISART member since 2020, hosting a collaborative workshop with the society at their booth during RehabWeek 2025.
Fourier Rehab has proudly been an IISART (International Industry Society in Advanced Rehabilitation Technology) member since 2020. During RehabWeek 2025, the company co-hosted a dynamic workshop with IISART at its booth, facilitating knowledge exchange and technical deep dives with global attendees. In addition, the company also partnered with STEPS to conduct a dedicated workshop centered around the ExoMotus™ M4, offering participants firsthand insight into its clinical utility and features.
As Fourier Rehab continues to expand its portfolio of intelligent rehabilitation solutions, it remains focused on bridging the gap between robotics, AI, and real-world clinical practice. With strong momentum from RehabWeek 2025, the company is positioned to lead the next wave of advancements in neurorehabilitation worldwide.